Crescent Biopharma, Inc.

CBIONASDAQHealthcare● Active

$17.28

$-0.72(-4.00%)

Market Cap$476442432

P/E Ratio—

52W High$27.41

52W Low$8.72

Avg Volume276K

Open$18.27

Beta1.15

Overview

Crescent Biopharma, Inc.（CBIO）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · CBIO · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

∞

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 100%仅显示有效交易 · 排除RSU归属0% Sell ↓

Crescent Biopharma, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

CBIO 季度内部人买卖趋势

CBIO 内幕交易卖出 · CBIO 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

2.8M1.4M0

2023 Q4

2024 Q1

2024 Q2

2024 Q3

2025 Q2

2025 Q3

2025 Q4

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

近期内幕交易记录

CBIO 高管卖出股份 · CBIO 董事内幕交易 · SEC Form 4申报

显示最近 28 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Aug 7, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	61,488	$0.18	$11K	6,578,438	Form 4
Aug 8, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	260,873	$0.19	$50K	6,317,565	Form 4
Aug 5, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	164,523	$0.19	$31K	6,695,658	Form 4
Aug 6, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	55,732	$0.18	$10K	6,639,926	Form 4
Aug 1, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	63,564	$0.22	$14K	7,146,381	Form 4
Aug 2, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	286,200	$0.20	$57K	6,860,181	Form 4
Jul 26, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	258,335	$0.24	$62K	8,330,729	Form 4
Jul 29, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	363,949	$0.24	$86K	7,966,780	Form 4
Jul 30, 2024	Invus Public Equities, L.P. 10 percent owner	Sale	756,835	$0.22	$167K	7,209,945	Form 4
Jun 21, 2024	Rock Edwin Chief Medical Officer	Purchase	115,000	$0.27	$31K	680,403	Form 4
Jun 20, 2024	Rock Edwin Chief Medical Officer	Purchase	190,000	$0.25	$48K	565,403	Form 4
Jun 18, 2024	Hahn Brian M. SVP Finance, CFO	Purchase	17,500	$0.25	$4K	70,643	Form 4
Mar 29, 2024	JUNIUS DANIEL M Director	Award	5,209	$3.00	$16K	98,459	Form 4
Mar 29, 2024	King Rachel K. Director	Award	3,334	$3.00	$10K	515,194	Form 4
Mar 29, 2024	Goldberg Mark Alan Director	Award	4,584	$3.00	$14K	24,828	Form 4
Sep 22, 2023	Rock Edwin Chief Medical Officer	Purchase	30,403	$1.38	$42K	375,403	Form 4
Sep 21, 2023	Rock Edwin Chief Medical Officer	Purchase	35,000	$1.38	$48K	345,000	Form 4
Jun 1, 2023	Koenig Scott Director	Option	21,000	$0.60	$13K	36,750	Form 4
May 17, 2023	Hahn Brian M. SVP Finance, CFO	Sale	3,700	$1.95	$7K	53,143	Form 4
May 10, 2023	JUNIUS DANIEL M Director	Purchase	30,000	$1.56	$47K	93,250	Form 4
May 8, 2023	Johnson Bruce S SVP & Chief Commercial Officer	Purchase	13,500	$1.57	$21K	138,980	Form 4
Feb 24, 2023	Invus Public Equities, L.P. 10 percent owner	Purchase	100,000	$1.70	$170K	8,589,064	Form 4
Feb 23, 2023	Invus Public Equities, L.P. 10 percent owner	Purchase	200,000	$1.75	$351K	8,489,064	Form 4
Feb 22, 2023	Invus Public Equities, L.P. 10 percent owner	Purchase	150,000	$1.79	$269K	8,289,064	Form 4
Feb 21, 2023	Invus Public Equities, L.P. 10 percent owner	Purchase	50,000	$1.85	$93K	8,139,064	Form 4

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Aug 7

股数

61,488

均价

$0.18

总金额

$11K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Aug 8

股数

260,873

均价

$0.19

总金额

$50K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Aug 5

股数

164,523

均价

$0.19

总金额

$31K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Aug 6

股数

55,732

均价

$0.18

总金额

$10K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Aug 1

股数

63,564

均价

$0.22

总金额

$14K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Aug 2

股数

286,200

均价

$0.20

总金额

$57K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Jul 26

股数

258,335

均价

$0.24

总金额

$62K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Jul 29

股数

363,949

均价

$0.24

总金额

$86K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Sale

日期

Jul 30

股数

756,835

均价

$0.22

总金额

$167K

View Form 4 on SEC.gov

Rock Edwin

Chief Medical Officer

Purchase

日期

Jun 21

股数

115,000

均价

$0.27

总金额

$31K

View Form 4 on SEC.gov

Rock Edwin

Chief Medical Officer

Purchase

日期

Jun 20

股数

190,000

均价

$0.25

总金额

$48K

View Form 4 on SEC.gov

Hahn Brian M.

SVP Finance, CFO

Purchase

日期

Jun 18

股数

17,500

均价

$0.25

总金额

$4K

View Form 4 on SEC.gov

JUNIUS DANIEL M

Director

Award

日期

Mar 29

股数

5,209

均价

$3.00

总金额

$16K

View Form 4 on SEC.gov

King Rachel K.

Director

Award

日期

Mar 29

股数

3,334

均价

$3.00

总金额

$10K

View Form 4 on SEC.gov

Goldberg Mark Alan

Director

Award

日期

Mar 29

股数

4,584

均价

$3.00

总金额

$14K

View Form 4 on SEC.gov

Rock Edwin

Chief Medical Officer

Purchase

日期

Sep 22

股数

30,403

均价

$1.38

总金额

$42K

View Form 4 on SEC.gov

Rock Edwin

Chief Medical Officer

Purchase

日期

Sep 21

股数

35,000

均价

$1.38

总金额

$48K

View Form 4 on SEC.gov

Koenig Scott

Director

Option

日期

Jun 1

股数

21,000

均价

$0.60

总金额

$13K

View Form 4 on SEC.gov

Hahn Brian M.

SVP Finance, CFO

Sale

日期

May 17

股数

3,700

均价

$1.95

总金额

$7K

View Form 4 on SEC.gov

JUNIUS DANIEL M

Director

Purchase

日期

May 10

股数

30,000

均价

$1.56

总金额

$47K

View Form 4 on SEC.gov

Johnson Bruce S

SVP & Chief Commercial Officer

Purchase

日期

May 8

股数

13,500

均价

$1.57

总金额

$21K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Purchase

日期

Feb 24

股数

100,000

均价

$1.70

总金额

$170K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Purchase

日期

Feb 23

股数

200,000

均价

$1.75

总金额

$351K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Purchase

日期

Feb 22

股数

150,000

均价

$1.79

总金额

$269K

View Form 4 on SEC.gov

Invus Public Equities, L.P.

10 percent owner

Purchase

日期

Feb 21

股数

50,000

均价

$1.85

总金额

$93K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 CBIO 内幕交易

CBIO 内幕交易

Crescent Biopharma, Inc.（CBIO）内幕交易数据来源于公司内部人（包括CBIO）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。CBIO内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Crescent Biopharma, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

CBIO 内幕交易 · 5个问题

Crescent Biopharma, Inc.（CBIO）的内部人包括高管和董事，如CBIO等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

CBIO 董事内幕交易CBIO 内部人名单Crescent Biopharma, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026